Literature DB >> 17186410

Immunohistochemical study of phospho-Stat3-ser727 expression in feline mammary gland tumours.

C Petterino1, G Podestà, A Ratto, M Drigo, C Pellegrino.   

Abstract

We describe the expression of pStat3-ser727 (signal transducer and activator of transcription 3 phosphorylated on serine 727) in normal, hyperplastic and neoplastic feline mammary gland tissue assessed by immunohistochemistry in 56 cats. The samples included 4 normal mammary non-lactating tissues, 13 hyperplastic lesions (9 lobular and 4 fibroepithelial) and 39 tumours (6 benign and 33 carcinomas). For immunohistochemistry, tissue sections were incubated with anti-pStat3-ser727 monoclonal antibodies and visualized with EnVision-DAB polymer. pStat3-ser727 positivity was quantified in a semi-quantitative manner, differentiating cytoplasmic and nuclear localization. Intense anti-pStat3-ser727 immunoreactivity was detected in epithelial neoplastic cells and in the fibro-component in two fibroepithelial hyperplastic lesions. The immunostaining was dot-like in the cytoplasm and homogeneous in the nuclei in both benign and malignant lesions. Statistically significant relations were observed between nuclear expression of pStat3-ser727 and the pleomorphism score (p = 0.006), mitotic activity (p < 0.0001), and histological grade (p < 0.0001). In contrast, no significant correlations were observed for cytoplasmic pStat3-ser727. These findings add new and interesting information on the potential role of the phosphorylated form of Stat3 in malignant lesions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17186410     DOI: 10.1007/s11259-006-3330-4

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  20 in total

Review 1.  What does Stat3 do?

Authors:  David E Levy; Chien-kuo Lee
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

2.  Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation.

Authors:  Z Wen; Z Zhong; J E Darnell
Journal:  Cell       Date:  1995-07-28       Impact factor: 41.582

3.  Expression of Stat3 in feline mammary gland tumours and its relation to histological grade.

Authors:  C Petterino; A Ratto; E Arcicasa; G Podestà; M Drigo; C Pellegrino
Journal:  Vet Res Commun       Date:  2006-08       Impact factor: 2.459

4.  Immunohistochemical study of STAT3 expression in feline injection-site fibrosarcomas.

Authors:  C Petterino; M Martano; P Cascio; F Cerruti; M Martini; E Morello; R Bruno; M Castagnaro; Paolo Buracco
Journal:  J Comp Pathol       Date:  2006-01       Impact factor: 1.311

5.  Extracellular signal-regulated protein kinase (ERK)-dependent and ERK-independent pathways target STAT3 on serine-727 in human neutrophils stimulated by chemotactic factors and cytokines.

Authors:  M Kuroki; J T O'Flaherty
Journal:  Biochem J       Date:  1999-08-01       Impact factor: 3.857

6.  Repression of Stat3 activity by activation of mitogen-activated protein kinase (MAPK).

Authors:  N Jain; T Zhang; S L Fong; C P Lim; X Cao
Journal:  Oncogene       Date:  1998-12-17       Impact factor: 9.867

7.  Stat3 activation in acute lung injury.

Authors:  Hongwei Gao; Ren-Feng Guo; Cecilia L Speyer; Jayne Reuben; Thomas A Neff; L Marco Hoesel; Niels C Riedemann; Shannon D McClintock; J Vidya Sarma; Nico Van Rooijen; Firas S Zetoune; Peter A Ward
Journal:  J Immunol       Date:  2004-06-15       Impact factor: 5.422

8.  Cell proliferation in feline normal, hyperplastic and neoplastic mammary tissue--an immunohistochemical study.

Authors:  P Dias Pereira; J Carvalheira; F Gärtner
Journal:  Vet J       Date:  2004-09       Impact factor: 2.688

Review 9.  Activation of STAT transcription factors in oncogenic tyrosine kinase signaling.

Authors:  R Garcia; R Jove
Journal:  J Biomed Sci       Date:  1998       Impact factor: 8.410

10.  Elevated levels of members of the STAT family of transcription factors in breast carcinoma nuclear extracts.

Authors:  C J Watson; W R Miller
Journal:  Br J Cancer       Date:  1995-04       Impact factor: 7.640

View more
  4 in total

1.  Suppressor of cytokine signaling-2 gene disruption promotes Apc(Min/+) tumorigenesis and activator protein-1 activation.

Authors:  Victoria A Newton; Nicole M Ramocki; Brooks P Scull; James G Simmons; Kirk McNaughton; P Kay Lund
Journal:  Am J Pathol       Date:  2010-03-26       Impact factor: 4.307

2.  Investigating the role of signal transducer and activator of transcription 3 in feline injection site sarcoma.

Authors:  Cheng-Hsin Shih; Yen-Chen Chang; Yun-Chiang Lai; Hue-Ying Chiou
Journal:  BMC Vet Res       Date:  2022-07-14       Impact factor: 2.792

Review 3.  The Multifaceted Role of STAT3 in Mammary Gland Involution and Breast Cancer.

Authors:  Katherine Hughes; Christine J Watson
Journal:  Int J Mol Sci       Date:  2018-06-07       Impact factor: 5.923

Review 4.  Companion Animals as Models for Inhibition of STAT3 and STAT5.

Authors:  Matthias Kieslinger; Alexander Swoboda; Nina Kramer; Barbara Pratscher; Birgitt Wolfesberger; Iwan A Burgener
Journal:  Cancers (Basel)       Date:  2019-12-17       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.